Greenfield Shelly F, Manwani Sumita G, Nargiso Jessica E
Harvard Medical School, USA.
Obstet Gynecol Clin North Am. 2003 Sep;30(3):413-46. doi: 10.1016/s0889-8545(03)00072-x.
Significant gender differences exist in the prevalence of substance use disorders in the United States. There is a trend among boys and girls aged 12 to 17 years toward comparable rates of use and initiation for alcohol, cocaine, heroin, and tobacco. If this trend continues, over time there may be a narrowing of the male-to-female prevalence ratios of substance abuse in the older age groups. This possibility is particularly disturbing because women have a heightened vulnerability to medical, physical, mental, and social consequences of substance use. Women also carry additional unique risks during pregnancy because of the effect on neonates. In addition, they have certain gender-specific cancer risks. Given this and the declining age of initiation of substance use in women, prevention and treatment efforts especially geared toward women (eg, education of all medical and paramedical staff, screening in primary care clinics, detection of drug use early in pregnancy or before conception, brief interventions and treatment programs that integrate women's needs) are exceedingly important to stop and ultimately reverse this growing trend.
在美国,物质使用障碍的患病率存在显著的性别差异。12至17岁的男孩和女孩在酒精、可卡因、海洛因和烟草的使用及开始使用的比率上有趋同的趋势。如果这一趋势持续下去,随着时间的推移,老年人群体中物质滥用的男女患病率之比可能会缩小。这种可能性尤其令人不安,因为女性对物质使用的医学、身体、心理和社会后果更为脆弱。由于对新生儿的影响,女性在怀孕期间还面临额外的独特风险。此外,她们还有特定的性别相关癌症风险。鉴于此以及女性开始使用物质的年龄不断下降,特别针对女性的预防和治疗措施(例如,对所有医疗和辅助医疗人员进行教育、在初级保健诊所进行筛查、在怀孕早期或受孕前检测药物使用情况、整合女性需求的简短干预和治疗方案)对于阻止并最终扭转这一日益增长的趋势极为重要。